BTG is a dedicated ally to healthcare providers treating patients with critical conditions, focusing on emergency care and rare diseases. For over 30 years we have made treating these complex and life-threatening conditions possible; supporting clinicians, healthcare systems and governments while offering hope to patients and their families.  

As a fully integrated company, we have the experience and capabilities to acquire, develop, and manufacture our medicines to the highest standards, and make them available worldwide through our secure supply chain.

Improving patients’ quality of life and offering hope is what motivates and inspires us.

BTG was acquired by SERB Pharmaceuticals in 2020. SERB now operates in the US as BTG Pharmaceuticals. 

Health Care

BTG Pharmaceuticals

Anthony Higham

Sam Elcomb

Thomas Kolaras

Antoine Bernasconi

Vincent Sainte - Catherine

Marie Botin

Christon Hill

Bich Pham - Huy

Ben Watt

Arthur Pignot

The Leadership Team at BTG Pharmaceuticals is responsible for setting and executing the company's strategic direction, ensuring operational excellence, and fostering innovation in the development and supply of treatments for critical and rare conditions. This team collaborates to make high-level decisions that drive the company's mission to improve patients' quality of life and maintain high standards across all operations, while also coordinating efforts between the U.S. and international markets.

Leadership Team

Commercial Strategy Team

Business Strategy and Analysis

Leadership Team

About

Team members

Other teams at BTG Pharmaceuticals

Commercial Strategy Team

Business Strategy and Analysis